The most powerful
biomarker discovery platform
GEMMAai™
GEnoMic Marker Analyzer
AI-Powered platform for matching patients with right treatment
GEMMAai for clinical trial enrolment – available *
GEMMAai for companion diagnostics development – available *
GEMMAai for patients coming soon – pipeline *
TUMOR
TYPE
TUMOR GENOMES
TARGETED THERAPY
DISCOVERY
PROTOTYPE ASSAY
ANALITYCAL VALIDATION
CLINICAL VALIDATION
REGULATORY APPROVAL
UPCOMING
MILESTONES
BREAST
2152
CDK4/6i
Ant-HER2
PARPi
mTORi
PIK3i
2 analytically validated diagnostic tools in Q1 2021
OVARIAN
512
Carboplatin / PARPi
FDA breakthrough device submission Q2 2021
FASETM
GENOMIC FEATURE DATABASE
YOUR inhibitor
Discovery and validation
AI-POWERED
STRATIFICATION DIAGNOSTIC TOOL
Learn more
* For Research Use Only. Not for use in diagnostic procedures.
TUMOR TYPE: OVARIAN
WGS DATA
512
TARGETTED THERAPY
UPCOMING MILESTONES
FDA breakthrough device in Q3 2021
TUMOR TYPE: BREAST
WGS DATA
2152
TARGETTED THERAPY
UPCOMING MILESTONES
2 analytically validated diagnostic tools in Q1 2021
TUMOR TYPE: LUNG
WGS DATA
1852
TARGETTED THERAPY
UPCOMING MILESTONES
2 prototype assays in Q3 2021
FUSETM
WGS DATA
GENOMIC FEATURE DATABASE
TARGETTED THERAPY
YOUR inhibitor
DISCOVERY AND VALIDATION
AI-POWERED STRATIFICATION DIAGNOSTIC TOOL
Our publications
The First Report of Biallelic Missense Mutations in the SFRP4 Gene Causing Pyle Disease in Two Siblings
A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection
A somatic-mutational process recurrently duplicates germline susceptibility loci and tissue-specific super-enhancers in breast cancers
Initiatives
The Polish BioBanking Center was created to store tumor samples necessary for genomic cancer diagnostics. It gives patients a chance for better, personalized, and targeted cancer therapies. In addition, BioBanking provides scientists with access to biological samples for research purposes.
Learn more
Genetyka.bio is an online platform created by professionals, dedicated to sharing their knowledge with others. We provide scientifically proven, reliable information about genetics. We fight myths and pseudoscience.
Learn more
Analizagenomu.pl was the first whole-genome sequencing-based clinical diagnostics program in Poland. It was dedicated to patients suffering from congenital metabolic skeletal disorders, who could undergo free genomic diagnostic to understand and to stop the development of the disease. Learn about Olek’s history.
Learn more
We have joined the covid19hg.org initiative, which brings together scientific groups engaged in research on the genetic aspects of coronavirus. To learn if individuals are susceptible to the SARS-CoV-2, we are performing over 1000 whole-genome sequencing analyses.
Learn more
Partners
